VDRM

ViaDerma Inc (PK)
0.0175
0.0016 (10.06%)

Period:

Draw Mode:

Volume 33,062,607
Bid Price 0.017
Ask Price 0.0181
News -
Day High 0.0199

Low
0.0044

52 Week Range

High
0.0185

Day Low 0.016
Company Name Stock Ticker Symbol Market Type
ViaDerma Inc (PK) VDRM OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0016 10.06% 0.0175 16:59:00
Open Price Low Price High Price Close Price Prev Close
0.016 0.016 0.0199 0.0175 0.0159
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
205 33,062,607 $ 0.018382 $ 607,744 - 0.0044 - 0.0185
Last Trade Time Type Quantity Stock Price Currency
16:02:06 formt 500,000 $ 0.017648 USD

ViaDerma Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 18.07M 1.03B 911.60M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
745.91k $ - - - -

more financials information »

ViaDerma (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VDRM Message Board. Create One! See More Posts on VDRM Message Board See More Message Board Posts

Historical VDRM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01180.0180.00820.01125129,614,2150.005748.31%
1 Month0.00580.0180.00440.00883048,784,0850.0117201.72%
3 Months0.006350.0180.00440.0079054,845,8430.01115175.59%
6 Months0.0130.0180.00440.00788742,727,2780.004534.62%
1 Year0.00680.01850.00440.00843932,282,7210.0107157.35%
3 Years0.0020.07650.00080.02060879,892,5870.0155775.0%
5 Years0.01070.07650.00080.01819757,038,6750.006863.55%

ViaDerma (PK) Description

ViaDerma, Inc. is a pharmaceutical company committed to bringing new products to the pharmaceutical industry through innovative research and development. The Company manufactures and sells products in fields of medicine ranging from infectious diseases to stem-cell therapy. The Company's products are normally applied topically using a patent-pending delivery system technology. Presently, the products are used within the OTC drug market, i.e. non-prescription. However, the Company believes the delivery system can be used for the prescription medication market as well not only for topical prescription medications but also to turn certain oral medications into topically based medications. In addition to the primary plan of developing and selling new products to the market, the Company is exploring the possibility of licensing the technology to other pharmaceutical companies. In addition to the primary plan of developing and selling new products to the market, the Company is exploring the possibility of licensing the technology to other pharmaceutical companies.